ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Impact of Immunosuppression Adherence on De Novo Donor-Specific Antibody Formation in Renal Transplant Recipients in Canada: A Modeling Analysis.

J. Howell,1 R. Pollock,2 J. Schwartz.3

1Astellas Pharma Global Development, Inc., Markham, ON, Canada
2Ossian Health Economics and Communications GmbH, Basel, Switzerland
3Astellas Pharma Global Development, Inc., Northbrook, IL

Meeting: 2017 American Transplant Congress

Abstract number: D78

Keywords: Antibodies, Graft survival, Kidney transplantation, Quality of life

Session Information

Session Name: Poster Session D: Kidney Immunosuppression: Novel Regimens and Drug Minimization

Session Type: Poster Session

Date: Tuesday, May 2, 2017

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall D1

Acute rejection rates and short-term graft survival have improved substantially as a result of advances in immunosuppression (IS), though longer-term graft survival rates have improved more modestly. Chronic immune-mediated injury driven by de novo donor-specific antibodies (dnDSA) has emerged as an important factor in longer-term graft loss. Using recently-published long-term data on adherence, dnDSA formation, and graft failure, the clinical effects of non-adherence associated with IS using prolonged-release tacrolimus (PR-TAC), immediate-release tacrolimus (IR-TAC), and cyclosporine (CsA) were modeled in Canadian renal transplant recipients.

A decision tree was developed to capture differences in adherence between IR-TAC, PR-TAC and CsA, and was combined with a five-state Markov model of dnDSA formation, graft failure and patient survival. Transition probabilities were determined by a series of Weibull, logistic, and least squares regression models. Adherence, quality of life, and patient and graft survival were derived from Canadian sources. Analyses were run over a 25 year time horizon.

Irrespective of IS treatment, reduced dnDSA incidence resulted in lower graft failure rates, increased life expectancy, and increased quality-adjusted life expectancy. In a population of exclusively non-adherent patients, the proportion experiencing dnDSA was 43.6% (CsA), 42.6% (IR-TAC) and 34.3% (PR-TAC). In these patients, use of PR-TAC resulted in a reduction in dnDSA of 19.4% relative to IR-TAC, and number needed to treat (NNT) of 12 to avoid dnDSA. In a more generalized population including both adherent and non-adherent patients (13% non-adherent with PR-TAC; 20% CsA and IR-TAC), dnDSA developed in 22.3% (CsA), 22.1% (IR-TAC) and 20.5% (PR-TAC) of patients. Relative to IR-TAC, NNT with PR-TAC to avoid dnDSA was 63; mean time to dnDSA onset was delayed to 7.9 years (difference 0.24 years).

Based on modern clinical data in adherent vs non-adherent patients, a modeling analysis projected that PR-TAC would reduce the incidence of dnDSA, and improve graft and patient survival relative to IR-TAC or CsA in Canadian renal transplant patients. Moreover, the beneficial effect of PR-TAC on dnDSA and clinical outcomes was most pronounced in non-adherent patients.

CITATION INFORMATION: Howell J, Pollock R, Schwartz J. Impact of Immunosuppression Adherence on De Novo Donor-Specific Antibody Formation in Renal Transplant Recipients in Canada: A Modeling Analysis. Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Howell J, Pollock R, Schwartz J. Impact of Immunosuppression Adherence on De Novo Donor-Specific Antibody Formation in Renal Transplant Recipients in Canada: A Modeling Analysis. [abstract]. Am J Transplant. 2017; 17 (suppl 3). https://atcmeetingabstracts.com/abstract/impact-of-immunosuppression-adherence-on-de-novo-donor-specific-antibody-formation-in-renal-transplant-recipients-in-canada-a-modeling-analysis/. Accessed May 10, 2025.

« Back to 2017 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences